CSWYFOTC Markets OTCPK
China Shineway Pharmaceutical Group Limited
$0.99
ListedOct 5, 2009
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryChina
Employees2822
State-| CityShijiazhuang| AddressLuan Cheng District| Phone-
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, chronic illnesses, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of Forway Investment Limited.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
4.8
?
Div. Rate
$0.00
?
Div. Yield
0.00%
?
Payout Ratio
36.74%
?
Max Consec. Div. Years
6 years
?
Longest Consec. Div.
6 years
?
Div. Coverage
69%
?
Div. Stability Rate
0.24
?
Div. Growth Rate
50.00%
?
Score
65

Dividend History

Historical dividend payments by ex-dividend date.

May 4, 2026
$ 0.0621
Sep 9, 2025
$ 0.0153
Apr 30, 2025
$ 0.0491
Sep 10, 2024
$ 0.0153
Apr 29, 2024
$ 0.0588
Sep 12, 2023
$ 0.0151
May 2, 2023
$ 0.0450
Sep 14, 2022
$ 0.0159
May 4, 2022
$ 0.0329
Sep 13, 2021
$ 0.0599
Jun 3, 2021
$ 0.0317
Oct 6, 2020
$ 0.0158
Oct 11, 2016
$ 0.0163
Jun 2, 2016
$ 0.0320
Oct 13, 2015
$ 0.0170
Jun 4, 2015
$ 0.0351
Oct 14, 2014
$ 0.0177
Jun 5, 2014
$ 0.0351
May 24, 2011
$ 0.0439
Oct 12, 2010
$ 0.0161
May 19, 2010
$ 0.0391

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!